SK bioscience announced that, together with IDT Biologika (IDT) and Australian biotechnology company Vaxxas, it has been ...

As shelf-stable microarray patch (MAP) platforms move through development and clinical work, a ‘packaging first’ mentality is needed for industry-wide adoption.

The statistical interaction between genetic susceptibility and lifestyle was significant in the larger cohort and showed similar directional trends in the Indian cohort, according to the study ...

Multiplexing Breakthroughs, Automation, and Bioinformatics Convergence Position Protein Microarrays as a Strategic Imperative for Precision Medicine LeadersDelray Beach, FL, Feb. 24, 2026 (GLOBE ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how ...

Vaxxas has been awarded a tender by the European Health and Digital Executive Agency to help develop next-generation ...

The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...

Explore essential statistical strategies for accurate protein quantification and differential expression analysis.

BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...

SK bioscience, IDT Biologika, and Vaxxas will collaborate on a next-generation influenza vaccine development initiative.

SK Bioscience said Thursday it has secured its first European Union-backed vaccine development project alongside German subsidiary IDT Biologika, marking a key ...